Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.
DocGo Inc. reports developments in technology-enabled mobile health, medical transportation, remote patient monitoring and virtual care. The company’s care delivery platform combines in-home or workplace treatment with remote physicians, a 50-state virtual care network and integrated Ambulnz medical transport services.
Recurring news themes include quarterly and annual results, revenue guidance, customer expansions, EMS hiring and efficiency initiatives, investor conference presentations, governance and compliance recognition, and activity at SteadyMD, DocGo’s virtual care division. Company updates also describe demand for clinician-led telehealth programs, including branded GLP-1 weight loss care support.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
DocGo (NASDAQ:DCGO) has announced a new multi-year preferred provider agreement with Fresenius Medical Care, the largest kidney dialysis treatment provider in the U.S. The collaboration, effective May 1, 2023, enhances DocGo's offerings in remote patient monitoring, chronic care management, and urgent care services. This partnership builds on a relationship established in 2019, allowing nephrologists to better manage the health of approximately 780,000 end-stage renal disease patients and millions of chronic kidney disease patients in the U.S. DocGo aims to deliver proactive health care, reducing hospitalization risks and improving patient outcomes through advanced technology and integration with Fresenius Medical Care's resources.